Castle Biosciences, Inc.
CSTL
$25.62
-$0.29-1.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 299.51M | 287.54M | 275.93M | 275.15M | 293.13M |
| Total Receivables | 44.48M | 50.68M | 53.31M | 56.95M | 51.82M |
| Inventory | 10.25M | 8.65M | 8.37M | 6.85M | 8.14M |
| Prepaid Expenses | 6.86M | 10.70M | 11.06M | 10.44M | 7.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 361.10M | 357.57M | 348.67M | 349.39M | 360.15M |
|
|
|||||
| Total Current Assets | 361.10M | 357.57M | 348.67M | 349.39M | 360.15M |
| Net Property, Plant & Equipment | 112.24M | 100.04M | 89.56M | 66.59M | 62.71M |
| Long-term Investments | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Goodwill | 10.69M | 10.69M | 10.69M | 10.69M | 10.69M |
| Total Other Intangibles | 88.88M | 91.16M | 93.43M | 67.21M | 95.54M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.65M | 3.33M | 2.37M | 2.27M | 2.15M |
| Total Assets | 578.56M | 562.79M | 544.73M | 501.72M | 531.24M |
|
|
|||||
| Total Accounts Payable | 18.71M | 12.21M | 13.18M | 8.50M | 6.90M |
| Total Accrued Expenses | 45.10M | 37.80M | 31.13M | 23.77M | 38.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.84M | 1.45M | 3.52M | 2.55M | 2.04M |
| Total Finance Division Other Current Liabilities | 3.02M | 3.84M | 3.06M | 2.45M | 1.75M |
| Total Other Current Liabilities | 3.02M | 3.84M | 3.06M | 2.45M | 1.75M |
| Total Current Liabilities | 68.68M | 55.31M | 50.89M | 37.27M | 49.39M |
|
|
|||||
| Total Current Liabilities | 68.68M | 55.31M | 50.89M | 37.27M | 49.39M |
| Long-Term Debt | 9.64M | 10.05M | 8.10M | 8.92M | 9.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.53M | 25.64M | 25.74M | 14.38M | 14.66M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.84M | 4.74M | 4.63M | 837.00K | 1.61M |
| Total Liabilities | 107.68M | 95.74M | 89.35M | 61.41M | 75.40M |
|
|
|||||
| Common Stock & APIC | 694.89M | 688.76M | 676.79M | 666.15M | 655.73M |
| Retained Earnings | -224.28M | -221.95M | -221.45M | -225.97M | -200.13M |
| Treasury Stock & Other | 267.00K | 240.00K | 39.00K | 131.00K | 230.00K |
| Total Common Equity | 470.87M | 467.05M | 455.38M | 440.31M | 455.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 470.87M | 467.05M | 455.38M | 440.31M | 455.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 470.87M | 467.05M | 455.38M | 440.31M | 455.84M |
|
|
|||||